CD138+ myeloma patient-derived plasma cells also displayed significantly higher CS1/SLAMF7 expression than myeloma CD138- BMMCs, HD CD138+ plasma cells and HD CD138- BMMCs. This evidence concerns the gene SLAMF7 and plasma cell myeloma.